- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Samjin Pharm (005500)
Assess today's live Samjin Pharm (005500) share price, performance and insights using our live Seoul: 005500 stock exchange data.
Analyse the historical data and Samjin Pharm share price performance charts on this page. Our technical summary section provides analysis on Samjin Pharm share price buy/sell indicators using real-time data (or discuss the Samjin Pharm (005500) stock price today with other investors in the Samjin Pharm KS share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current KS 005500 share price (ISIN: KR7005500004) to enhance your trading decisions with our free investment tools and resources.
What Is the Samjin Pharm Share Price Today?
The Samjin Pharm share price today is 24,700.
What Is the Stock Symbol for Samjin Pharm
The stock symbol (or 'ticker') for Samjin Pharm is "005500."
What Stock Exchange Does Samjin Pharm Trade On?
Samjin Pharm is listed and trades on the Seoul stock exchange.
Is Samjin Pharm a Good Stock to Buy?
Determining whether Samjin Pharm—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Samjin Pharm share price performance charts on this page. Our technical summary section provides analysis on Samjin Pharm share price buy/sell indicators using real-time data (or discuss the Samjin Pharm (005500) stock price today with other investors in the Samjin Pharm KS share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current KS 005500 share price (ISIN: KR7005500004) to enhance your trading decisions with our free investment tools and resources.
What Is the Samjin Pharm Share Price Today?
The Samjin Pharm share price today is 24,700.
What Is the Stock Symbol for Samjin Pharm
The stock symbol (or 'ticker') for Samjin Pharm is "005500."
What Stock Exchange Does Samjin Pharm Trade On?
Samjin Pharm is listed and trades on the Seoul stock exchange.
Is Samjin Pharm a Good Stock to Buy?
Determining whether Samjin Pharm—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Seoul
Currency in KRW
24,700
+4,760(+23.87%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
20,650
25,900
52 wk Range
16,990
25,900
Earnings results expected today
1/4
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
20,65025,900
52 wk Range
16,99025,900
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.24%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.24%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
005500 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
24,000
Downside
-2.83%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with high price volatility
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 24,000
(-2.83% Downside)
Earnings
Latest Release
17/03/2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / 92.4B
Compare 005500 to Peers and Sector
Metrics to compare | 005500 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship005500PeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | 5.8x | −0.5x | |
PEG Ratio | 0.00 | 0.01 | 0.00 | |
Price/Book | 0.0x | 1.0x | 2.6x | |
Price / LTM Sales | 0.0x | 0.7x | 3.2x | |
Upside (Analyst Target) | 0.0% | 48.8% | 55.3% | |
Fair Value Upside | Unlock | 7.7% | 9.7% | Unlock |
Samjin Pharmaceuticals Co., Ltd. manufactures and sells medicine. It offers medicine in oral, drop, and injecting forms. The company provides over-the-counter medicines, such as Gevorin, an anti-infalammatory pain killer; Trestan, an appetite stimulant; Flaris, an anti-thrombotic agent; and Nutilin, a brain function improvement agent, as well as medicine for treatment of chronic diseases. It also develops SA001, which is in Phase II clinical trial for the treatment for dry eye syndrome and Sjogren syndrome; SJP1804 medicine that is Phase I clinical trial to treat macular degeneration; and SJP1604, which is in Phase I clinical trial for cancer; SJP1901 and SJP1902 for cancer treatment; SJP 1801 to treat Alzheimer’s and Parkinson’s disease; SJP006, an anti-viral product; and SJP003 for treatment of diabetes. In addition, the company's preclinical product is SJP1602 for the treatment of cancer. Samjin Pharmaceuticals Co., Ltd. was founded in 1968 and is headquartered in Seoul, South Korea.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Samjin Pharm (Seoul: 005500) Share Price Today?
The Samjin Pharm stock price today is 24,700 KRW.
What Stock Exchange Does Samjin Pharm (005500) Trade On?
Samjin Pharm is listed and trades on the Seoul Stock Exchange.
What Is the Ticker (Stock Symbol) for Samjin Pharm?
The stock symbol (also called a 'ticker') for Samjin Pharm is "005500."
Does Samjin Pharm Pay Dividends? What’s The Current 005500 Dividend Yield?
Yes, 005500 Pays Dividends to its Shareholders. The current Samjin Pharm dividend yield is 3.24%.
What Is the Current Samjin Pharm Market Capitalisation?
As of today, Samjin Pharm (Seoul: 005500) market cap is 302.77B KRW.
What Is Samjin Pharm's (005500) Earnings Per Share (TTM)?
The Samjin Pharm EPS is currently 1,728 (Trailing Twelve Months).
When Is the Next Samjin Pharm Earnings Date?
Samjin Pharm's next earnings report will be released on 19/05/2026.
Is 005500 a Buy or Sell From a Technical Analyst Perspective?
Based on today's Samjin Pharm moving averages and other technical indicators, the daily buy/sell signal for 005500 stock is Strong Buy.
How Many Times Has Samjin Pharm Stock Split?
Samjin Pharm has split 6 times. (See the 005500 stock split history page for full effective split date and price information.)
How Many Employees Does Samjin Pharm Have?
Samjin Pharm has 586 employees, based on their latest Companies House report.
What is the current trading status of Samjin Pharm (Seoul: 005500)?
As of 19/05/2026, Samjin Pharm (005500) is trading at a share price of 24,700 KRW, with a previous close of 24,700 KRW. The stock has fluctuated within a day range of 20,650 KRW to 25,900 KRW, while its 52-week range spans from 16,990 KRW to 25,900 KRW.
What Is Samjin Pharm (005500) Price Target According to Analysts?
The average 12-month price target for Samjin Pharm is 24,000 KRW, with a high estimate of 24000 KRW and a low estimate of 24000 KRW. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an -2.83% Downside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.